Skip to main content
SpringerLink
Log in

Bleeding and Coagulopathy

  • Chapter
Handbook of Hematologic and Oncologic Emergencies

  • 67 Accesses

Abstract

Anemia is not an uncommon finding in patients with malignancy, and the etiology is often multifactorial. In patients with hematologic malignancies, anemia is usually due to the lack of production of red blood cells, rather than blood loss, but it may be due to both. In patients with solid tumors, the anemia is usually that of chronic disease, a state of impaired iron utilization and therefore decreased blood production.1–3

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bentley DP: Anemia and chronic disease. Clin Haematol 11: 465–477, 1982.

    PubMed  CAS  Google Scholar 

  2. Cartwright GE: The anemia of chronic disorders. Semin Hematol 3: 351–374, 1966.

    PubMed  CAS  Google Scholar 

  3. Cartwright GE, Lee GR: Annotation: The anemia of chronic disorders. Br J Haematol 21: 147–152, 1971.

    Article  PubMed  CAS  Google Scholar 

  4. Dutcher JP, Schiffer CA, Aisner J, et al: Incidence of thrombocytopenia and bleeding among patients with solid tumors. Cancer 53: 557–562, 1984.

    Article  PubMed  CAS  Google Scholar 

  5. Roy AJ, Jafe N, Djerassi I: Prophylactic platelet transfusions in children with acute leukemia: A dose-response study. Transfusion 13: 283–290, 1973.

    Article  PubMed  CAS  Google Scholar 

  6. Schiffer CA, Aisner J: Platelet and granulocyte transfusion therapy for patients with cancer, Petz LD, Swisher SN (eds): Clinical Practice of Blood Transfusion. New York, Churchill Livingstone, 1981, pp 551–572.

    Google Scholar 

  7. Schiffer CA, Aisner J, Daly PA: Platelet transfusion for thrombocytopenic cancer patients, Klastersky J, Staquet MJ (eds): Medical Complications in Cancer Patients. New York, Raven Press, 1981, pp 37–49.

    Google Scholar 

  8. Dutcher JP, Schiffer CA, Aisner J, et al: Alloimmunization following platelet transfusion: The absence of a dose-response relationship. Blood 57: 395–398, 1981.

    PubMed  CAS  Google Scholar 

  9. Halohan TV, Terasaki PH, Deisseroth AB: Suppression of transfusion-related alloimmunization in intensively treated cancer patients. Blood 58: 122–128, 1981.

    Google Scholar 

  10. Hogge DE, Dutcher JP, Aisner J, Schiffer CA: Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion. Am J Hematol 14: 363–369, 1983.

    Article  PubMed  CAS  Google Scholar 

  11. Daly PA, Schiffer CA, Aisner J, Wiernik PH: Platelet transfusion therapy: One hour post-transfusion increments are valuable in predicting the need for HLA-matched preparations. J Am Med Assoc 243: 435–438, 1980.

    Article  CAS  Google Scholar 

  12. Schiffer CA, Aisner J, Wiernik PH: Frozen autologous platelet transfusion for patients with leukemia. N Engl J Med 299: 7–12, 1978.

    Article  PubMed  CAS  Google Scholar 

  13. Sack GM, Levin J, Bell WR: Trousseau’s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: Clinical, pathophysiologic and therapeutic features. Medicine (Baltimore) 56: 1–37, 1977.

    Google Scholar 

  14. Rickles FR, Edwards RL: Activation of blood coagulation in cancer: Trousseau’s syndrome revisited. Blood 62: 14–31, 1983.

    PubMed  CAS  Google Scholar 

  15. Brain MC, Azzopardi JG, Baker LRI: Microangiopathic haemolytic anemia in mucin-forming adenocarcinoma. Br J Haematol 18: 183–193, 1970.

    Article  PubMed  CAS  Google Scholar 

  16. Shafer AI: The hypercoagulable states. Ann Intern Med 102: 814–828, 1985.

    Article  Google Scholar 

  17. Gore JM, Applebaum JS, Greene HL, Dixter L, Dalen JE: Occult cancer in patients with acute pulmonary embolism. Ann Intern Med 96: 556–560, 1982.

    Article  PubMed  CAS  Google Scholar 

  18. Daly PA, Schiffer CA, Wiernik PH: Acute progranulocytic leukemia—Clinical management of 15 patients. Am J Hematol 8: 347–359, 1980.

    Article  PubMed  CAS  Google Scholar 

  19. Gralnick HK, Bagley J, Abrel E: Heparin treatment for the hemorrhagic diathesis of acute progranulocytic leukemia. Am J Med 52: 167–174, 1971.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

    Authors
    1. Janice P. Dutcher M.D.
      View author publications

      You can also search for this author in PubMed Google Scholar

    Editor information

    Editors and Affiliations

    1. Division of Medical Oncology, Department of Medicine, Albert Einstein College of Medicine, 10461, Bronx, New York, USA

      Janice P. Dutcher M.D. (Associate Professor of Medicine) (Associate Professor of Medicine)

    2. Department of Oncology, Montefiore Medical Center, 10461, Bronx, New York, USA

      Janice P. Dutcher M.D. (Associate Professor of Medicine) (Associate Professor of Medicine)

    3. Department of Oncology, Montefiore Medical Center, 10467, Bronx, New York, USA

      Peter H. Wiernik M.D. (Gutman Professor and Chairman, Director, Associate Director for Clinical Research) (Gutman Professor and Chairman, Director, Associate Director for Clinical Research)

    4. Division of Medical Oncology, Albert Einstein College of Medicine, 10467, Bronx, New York, USA

      Peter H. Wiernik M.D. (Gutman Professor and Chairman, Director, Associate Director for Clinical Research) (Gutman Professor and Chairman, Director, Associate Director for Clinical Research)

    5. Albert Einstein Cancer Center, 10467, Bronx, New York, USA

      Peter H. Wiernik M.D. (Gutman Professor and Chairman, Director, Associate Director for Clinical Research) (Gutman Professor and Chairman, Director, Associate Director for Clinical Research)

    Rights and permissions

    Reprints and permissions

    Copyright information

    © 1987 Springer Science+Business Media New York

    About this chapter

    Cite this chapter

    Dutcher, J.P. (1987). Bleeding and Coagulopathy. In: Dutcher, J.P., Wiernik, P.H. (eds) Handbook of Hematologic and Oncologic Emergencies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0476-8_13

    Download citation

    • DOI: https://doi.org/10.1007/978-1-4899-0476-8_13

    • Publisher Name: Springer, Boston, MA

    • Print ISBN: 978-1-4899-0478-2

    • Online ISBN: 978-1-4899-0476-8

    • eBook Packages: Springer Book Archive

    Publish with us

    Policies and ethics

    Search

    Navigation